Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Fresh Cut Development LLC holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently features 2 pending office actions. Both of these actions are being handled by 1 distinct examiner within 1 distinct art unit, which indicates a high level of concentration for the company's active patent matters. This structure suggests that the company's current filings are closely related and are being reviewed as a cohesive group by the patent office.
LEE, WILLIAM Y is the busiest examiner for this portfolio, with 2 busiest examiner pending office actions. This count matches the total 2 pending office actions for the company, meaning this single examiner is responsible for the entirety of the company's current prosecution workload. The focus within 1 distinct art unit suggests that the company's active filings are technically related and are being reviewed within a 1 specialized group. For the applicant, this means that the prosecution strategy must be tailored to the specific examination style and technical requirements of this 1 examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, WILLIAM Y | 2 | 48.0% | +34.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17519844 | STABLE CANNABINOID FORMULATIONS | LEE, WILLIAM Y | 30d overdue |
| 17559155 | STABLE CANNABINOID FORMULATIONS | LEE, WILLIAM Y | — |
| Art Unit | Apps |
|---|---|
| 1623 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17559155 | STABLE CANNABINOID FORMULATIONS | LEE, WILLIAM Y | 1623 | §103 | Non-Final OA | — | Pending | Dec 22, 2021 |
| 17519844 | STABLE CANNABINOID FORMULATIONS | LEE, WILLIAM Y | 1623 | §103 | Final Rejection | 30d overdue | Pending | Nov 05, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFresh Cut Development LLC has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
William Y Lee has the most, with 2 of Fresh Cut Development LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
